Claire Morel

Comparative Analysis of Durable Responses on Immune Checkpoint Inhibitors Versus Other Systemic Therapies: A Pooled Analysis of Phase III Trials

Elvire Pons‐Tostivint, Aurélien Latouche, Pauline Vaflard et al. · JCO Precision Oncology · 2019 · 95 citations

Moderate-Intensity Continuous Training or High-Intensity Interval Training with or without Resistance Training for Altering Body Composition in Postmenopausal Women

Marine Dupuit, Mélanie Rance, Claire Morel et al. · Medicine & Science in Sports & Exercise · 2019 · 63 citations · Full text

Immune gene expression in head and neck squamous cell carcinoma patients

Charlotte Lecerf, Maud Kamal, Sophie Vacher et al. · European Journal of Cancer · 2019 · 62 citations · Full text

Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie

Clémence Basse, Claire Morel, Marie Alt et al. · ESMO Open · 2018 · 55 citations · Full text

Dual inhibition of ATR and ATM potentiates the activity of trabectedin and lurbinectedin by perturbing the DNA damage response and homologous recombination repair

Michelle de Souza Lima, Hana Bouzid, Daniele G. Soares et al. · Oncotarget · 2016 · 27 citations · Full text